Products 155213-67-5
CAS 155213-67-5 appears in our catalog under these names: Ritonavir, min. 95 %, 5 g, Ritonavir, Ritonavir, >95% (HPLC), Ritonavir/ 100%, Ritonavir–13C,d3. Offered by: Roth, GLPBio, Chemat Brand, Mikromol, LoGiCal. Available pack sizes: 5g, 5mg, on request, 100mg, 10mg, 50mg, 1g, 25mg.
Ritonavir is an L-valine derivative that is L-valinamide in which alpha-amino group has been acylated by a [(2-isopropyl-1,3-thiazol-4-yl)methyl]methylcarbamoyl group and in which a hydrogen of the carboxamide amino group has been replaced by a (2R,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl group. A CYP3A inhibitor and antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS, it is often used as a fixed-dose combination with another protease inhibitor, lopinavir. Also used in combination with dasabuvir sodium hydrate, ombitasvir and paritaprevir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver. It has a role as a HIV protease inhibitor, a xenobiotic, an antiviral drug and an environmental contaminant. It is a carbamate ester, a carboxamide, a member of 1,3-thiazoles, a member of ureas and a L-valine derivative.
Source: ChEBI
| Molecular formula | C37H48N6O5S2 |
|---|---|
| Molecular weight | 720.9 g/mol |
| IUPAC name | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate |
| InChIKey | NCDNCNXCDXHOMX-XGKFQTDJSA-N |
| SMILES | CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O |
Computed by PubChem (NCBI)
Synonyms:
ritonavir, Norvir, Abbott 84538, Empetus, Ritomune, Ritovir, Viekirax, Viriton, Ritonavirum, PAXLOVID COMPONENT RITONAVIR